22 Nw, LP Anebulo Pharmaceuticals, Inc. Call Options Transaction History
22 Nw, LP
- $119 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ANEB
# of Institutions
20Shares Held
22.6MCall Options Held
0Put Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT3.04MShares$7.47 Million0.19% of portfolio
-
Mangrove Partners New York, NY2.53MShares$6.21 Million0.53% of portfolio
-
Morgan Stanley New York, NY399KShares$982,0780.0% of portfolio
-
Lvw Advisors, LLC350KShares$860,0570.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA216KShares$531,2390.0% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $63.1M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...